Recent Headlines
- Unusual Options Activity Insight: Tilray
- Ready for New Cannabis and Psychedelics Boom Ahead: CEOs of Aphria, Icanic Brands, Red Light Holland, and Tilray Discuss New Global Market Opportunities
- 3 Marijuana Stocks to Play the Green Rush in 2021
- Aphria price target raised by Cantor to reflect merger with Tilray as analyst deems earnings disappointing
- Aphria Posts Higher Revenue, Plans To Close Tilray Deal In Q2
- Aphria's stock soars after reporting surprise profit, giving a boost to merger partner Tilray
- Aphria Stock, Marijuana Stocks Rally On Sales Beat, But Analyst Cites These Concerns
- Aphria Shares Are Rallying After Quarterly Sales Beat Wall Street Forecasts
- Aphria Jumps on Strong Earnings Beat Ahead of Tilray Merger
- Aphria's stock surges after reporting surprise profit, revenue that rose above expectations
- Is Tilray (TLRY) Stock Outpacing Its Medical Peers This Year?
- The Zacks Analyst Blog Highlights: NVIDIA, JPMorgan, Beazer Homes USA, Tesla and Tilray
- Cannabis companies continue their rally as Curaleaf chairman applauds 'quicker' reform
- Analyzing Tilray's Unusual Options Activity
- Is Tilray Stock a Buy?
- Here're the 5 Top Stock Trades for 2021
- Cannabis-industry investors ‘are likely overestimating the odds for federal decriminalization,’ analyst says
- Tilray (KL) Looks Good: Stock Adds 5.3% in Session
- Marijuana stocks could see more than 50% boost, says top analyst
- Why Aurora Cannabis, Aphria, and Other Cannabis Stocks Rose Again Today
- Marijuana Stocks Jump On Democratic Senate; Are Any Good Buys Now?
- The Aphria-Tilray Merger Shows Just How Overpriced Canopy Growth Is
- Cannabis stocks surge on hopes Democrats' win in Georgia could spark US legalization
- Here's Why Tilray, Canopy Growth, Aphria, and HEXO All Soared Today
- Cannabis stocks rally on Georgia Senate race results
- Cannabis stocks stage strong rally as prospect of Democratic Senate spurs reform hopes
- Marijuana Stocks Surge With Democratic Senate Likely; Are Any Good Buys Now?
- Implications for markets from the Georgia runoff results
- Marijuana Stocks Rally As Georgia Runoffs Signal Democratic Senate, Lift Cannabis Reform Hopes
- ROCE Insights For Tilray
- Here’s what a ‘blue wave’ forming in Washington means for markets
- UPDATE: Cannabis stocks stage strong premarket rally on hopes the pro-reform Democrats may take the Senate
- Is the Options Market Predicting a Spike in Tilray (TLRY) Stock?
- Why Marijuana Stocks Tilray, HEXO, and Charlotte's Web Were on Fire Monday
- Is TLRY Stock A Buy Ahead Of Georgia Senate Runoffs?
- High-Risk Sundial Growers Worth a Look after the Pullback
- Is Aphria Stock a Buy?
- SHAREHOLDER ALERT: WeissLaw LLP Reminds ANCN, PRVL, TLRY, and GNBF Shareholders About Its Ongoing Investigations
- Does 1+1=3 for This Merger Between Two Cannabis Heavyweights?
- Investors in These 5 Marijuana Stocks Had a Rough 2020
- SHAREHOLDER ALERT: Halper Sadeh LLP Investigates the Following Companies - RESI, NAV, SNCA, TLRY, CLCT
- Lifshitz Law Firm, P.C. Announces Investigation of ANCN, BEAT, HMSY, SNCA, SPWH, TCP, TRP, TLRY, and APHA
- Is TLRY Stock A Buy After Surging On Aphria Merger Deal?
- HEXO Stock Can Climb Further
- ALERT: Halper Sadeh LLP Continues to Investigate the Following Mergers – ALSK, NAV, SNCA, TLRY
- WeissLaw LLP Reminds TCP, TLRY, WORK, and GNBF Shareholders About Its Ongoing Investigations
- Halper Sadeh LLP Investigates the Following Mergers; Shareholders are Encouraged to Contact the Firm – CATM, PRVL, TCP, TLRY
- Better Marijuana Stock: OrganiGram vs. Aphria
- Is Tilray Stock A Buy After Surging On Aphria Merger Deal?
- The 2 Best Cannabis Stocks to Own in 2021